Data Availability StatementData can be found from the Center of Excellence

Data Availability StatementData can be found from the Center of Excellence for Chang Gung Research Datalink (CORPG6D0163), Chang Gung Memorial Hospital (Chiayi, Taiwan) for researchers who meet the criteria for access to confidential data. platelet count. Gender and serum albumin level were the major determinants of variation in hemoglobin level. A modestly increased white cell count was seen in men as well as individuals with elevated apolipoprotein B levels, but it was inversely correlated with changes in age and serum albumin levels. Conversely, some variables, although statistically significantly associated with the hematological indices, only provided a trivial explanation for the heterogeneity observed. We further established predictive models for the approximate estimation of hematological indices in healthy adults. Our data indicate that age, gender, and serum levels of apolipoprotein B and albumin affect hematological indices in various ways. We also demonstrate that variation in hemogram could be successfully predicted by a number of clinical and laboratory parameters. Introduction Complete blood counts are one of the most commonly ordered laboratory blood assessments. Several key hematological indices, particularly the white blood cell (WBC) count and platelet count, have been associated with atherosclerotic diseases and cardiovascular deaths [1, 2]. Variation in the hemogram could, therefore, significantly contribute to meaningful clinical consequences. Epidemiologic studies suggest that age and gender are the major determinants in the heterogeneity of hematological indices [3C6], whereas more recent evidence have exhibited that lipid profiles also contribute to the Nobiletin inhibitor database change in these parameters [7, 8]. Furthermore, the disparate genetic backgrounds among ethnic groups may also play a role, as a genome-wide meta-analysis has identified 12 loci being associated with the variation in several hematological parameters [9]. However, our understanding of the impacts of clinical and biochemical parameters on key hematological indices, particularly their reciprocal conversation Nobiletin inhibitor database at a population level, is limited. Through a feedback program sponsored by the largest petrochemical corporation in Taiwan, a significant proportion of residents from two rural villages in southern Taiwan underwent an annual health examination in our hospital during the last 7 years. The results of these exams were kept in the Chang Gung Research Datalink of Chang Gung Memorial Hospital, Taiwan. We took advantage of this and retrieved data on age, gender, nutritional level, lipid profile, and hepatitis B or C serological testing results to study their association with several key Nobiletin inhibitor database hematological indices We analyzed the individual impact of each parameter around the changes in hemogram levels. Methods Study population With the establishment of the Sixth Naphtha Cracker Complex in southern Taiwan, the Formosa Plastics Group started a feedback program for residents of adjacent townships in 2010 2010. The program allowed inhabitants from Mailiao and Taishi villages of Yunlin county, Taiwan, to come to our hospital for free annual health exams. The epidemiological Nobiletin inhibitor database background as well as Rabbit Polyclonal to UTP14A the laboratory data of those examined individuals was retained in the Chang Gung Research Datalink of Chang Gung Memorial Hospital, Nobiletin inhibitor database Taiwan. Upon the approval of the current study by the IRB of Chang-Gung Memorial Hospital, we retrieved demographic information including age and gender, the results of hemogram and serological testing for hepatitis B (HBV) and C (HCV), and data around the levels of total cholesterol (TC), triglyceride (TG), apolipoprotein B (Apo-B), albumin, and hepatic transaminases of the participating individuals, for the current analysis. Only adults who were 18 years or older at the time of examination were included. All the clinical data, after assigning a coding number for each subject, were encrypted without identifiable personal information and provided to the investigators of the current study team. Hematological and biochemical measurements For blood cell analysis, a Sysmex XE-5000 hematology analyzer (Sysmex; Kope, Japan) was used [10]. Measurement of all biochemical parameters was performed using a Hitachi Labospect 008 clinical analyzer (Hitachi, Ltd.; Tokyo, Japan). The TC was assayed based on coupled enzymatic reactions, followed by spectrophotometric detection [11]. The Apo-B level was quantified by a turbidimetric immunoassay [12]. The bromocresol green dye-binding method was used to measure the serum albumin level [13]. Serum triglyceride.

Comments are closed.